Retrospective study of Western blot profiles in immune sera of natural dengue virus infections

Journal of Medical Virology

Volumn 57, Issue 3, 1999, Pages 322-330

  Se Thoe, S Y ^a,b   Ng, Mary Mah Lee ^a   Ling, A E ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Immunogenic; Primary and secondary infection; Structural proteins

Indexed keywords

DENGUE VACCINE; EPITOPE; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; HUMAN; IMMUNOBLOTTING; IMMUNOGENICITY; MAJOR CLINICAL STUDY; NONHUMAN; SEROPREVALENCE; SINGAPORE; VIRUS CAPSID; VIRUS ENVELOPE; VIRUS IMMUNITY; VIRUS STRAIN;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BLOTTING, WESTERN; CERCOPITHECUS AETHIOPS; DENGUE; HEMAGGLUTINATION INHIBITION TESTS; HOSPITALIZATION; HUMANS; IMMUNOGLOBULIN M; RETROSPECTIVE STUDIES; VERO CELLS;

EID: 0032908131     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199903)57:3<322::AID-JMV17>3.0.CO;2-5     Document Type: Article

References (26)

1. Bhamarapravati N, Yoksan S. 1997. Live attenuated tetravalent dengue vaccine. In: Gubler DJ, Kuno G, editors. Dengue and dengue hemorrhagic fever. CAB International. p 367-377. Wallingford, UK, Madison Ave, NY.
2. Bray M, Lai CJ. 1991. Dengue virus premembrane and membrane proteins elicit a protective immune response. Virology 185:505-508.
3. Bray M, Men R, Lai CJ. 1996. Monkey immunized with intertypic chimeric dengue viruses are protected against wild-type virus challenge. J Virol 70:4162-4166.
4. Churdboonchart V, Bhamaraprati N, Peampramprecha S, Sirinavin S. 1991. Antibodies against dengue viral proteins in primary and secondary dengue hemorrhagic fever. Am J Trop Med Hyg 44:481-493.
5. Falconar AKI, Young PR. 1991. Production of dimer-specific and dengue virus group cross-reactive mouse monoclonal antibodies to the dengue 2 virus non-structural glycoprotein NS1. J Gen Virol 72: 961-965.
6. Falgout B, Bray M, Schlesinger JJ, Lai CJ. 1990. Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis. J Virol 64:4356-4363.
7. Halstead SB. 1974. Etiologies of the experimental dengues of Silver and Simmons. Am J Trop Med Hyg 223:974-982.
8. Halstead SB. 1988. Pathogenesis of dengue: challenges to molecular biology. Science 239:476-486.
9. Halstead SB. 1989. Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenic cascade. Rev Infect Dis 11:S830-S839.
10. Halstead SB. 1990. Global epidemiology of dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health 21:636-641.
11. Hase T, Summers PL, Eckels KH, Baze WB. 1987. An electron and immunoelectron microscopic study of dengue-2 virus infection of cultured mosquito maturation events. Arch Virol 92:273-291.
12. Kaufman BM, Summers OL, Dubois DR and Eckels KH. 1987. Monoclonal antibodies against dengue 2 virus E-glycoprotein protect mice against lethal dengue infection. Am J Trop Med Hyg 36:427-434.
13. Kaufman BM, Summers PL, Dubois DR, Houston Cohen DR, Gentry MK, Timchak RL, Burke D, Eckels KH. 1989. Monoclonal antibodies for dengue virus prM glycoprotein protect mice against lethal dengue infection. Am J Trop Med Hyg 41:576-580.
14. Khin MM, Jirakanjanakit N, Yoksan SM Bhamarapravati N. 1994. Infection, dissemination, transmission and biological attributes of DEN 2, PDK 53 candidate vaccine virus after oral infection in Aedes aegypti. Am J Trop Med Hyg 51:864-869.
15. Kurane I, Brinton MA, Samson AL, Ennis FA. 1991. Dengue virus-specific, human CD4+ CD8-cytotoxic T-cell clones: multiple patterns of virus-cross reactivity recognized by NS3-specific T-cell clones. J Virol 65:1823-1828.
16. Kurane I, Dai L-C, Livingstone PG, Reed E, Ennis FA. 1993. Definition of an HLA-Dpw2-restricted epitope on NS3, recognized by a dengue virus serotype-cross-reactive human CD4+ CD8-cytotoxic T-cell clone. J Virol 67:6285-6288.
17. Monath TP. 1994. Dengue: the risks to developed and developing countries. Proc Natl Acad Sci USA. 91:2395-2400.
18. Papaevangelou G, Halstead SB. 1977. Infections with two dengue viruses in Greece in the 20th century. Did dengue hemorrhagic fever occur in the 1928 epidemic? J Trop Med 80:46-51
19. Putnak A, Feighny R, Burrous J, Cochran M, Hackett C, Smith G, Hoke C. 1991. Dengue-1 virus envelope glycoprotein gene expressed in recombinant baculovirus elicits virus-neutralizing antibody in mice and protects them from virus challenge. Am J Trop Med Hyg 45:159-167.
20. Putnak R, Cassidy K, Conforti N, Lee R, Sollazzo D, Truong T, Ing E, Dubois D, Sparkuhl J, Gastle W, Hoke C. 1996. Immunogenic and protective response in mice immunized with a purified, inactivated, dengue-2 virus vaccine prototype made in fetal rhesus lung cells. Am J Trop Med Hyg 55:504-510.
21. Schlesinger JJ, Brandriss MW, Walsh EE. 1987. Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1. J Gen Virol 68: 853-857.
22. Srivastava AK, Putnak JR, Warren RL, Hoke Jr CH. 1995. Mice immunized with a dengue type 2 virus E and NS1 fusion protein made in Escherichia coli are protected against lethal dengue virus infection. Vaccine 13:1251-1258.
23. Staropoli I, Frenkiel M-P, Megret F, Deubel V. 1997. Affinity-purified dengue-2 envelope glycoprotein induces neutralizing antibodies and protective immunity in mice. Vaccine 15:1946-1954.
24. Tadano M, Okuno Y, Fukunaga T, Fukai K. 1983. Retrospective serological studies on dengue epidemics in Osaka and Okinawa. Biken J 26:165-167.
25. Vaughn DW, Hoke Jr CH, Yoksan S, LaChance R, Innis BL, Rice RM, Bhamarapravati N. 1996. Testing of a dengue 2 live-attenuated vaccine (strain 16681 PDK 53) in the American volunteers. Vaccine 14:329-336.
26. Zhang YM, Hayes E, McCarthy T, Dubois D, Summers P, Eckels K, Chanock RM, Lai CJ. 1988. Immunization mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis. J Virol 62:3027-3031.